MedWatch

Lawyers: The death of entrepreneurial tax gives way to biotech investments

The Danish pariament’s agreement to remove an entrepreneurial tax opens new possibilities in the biotech industry, but according to several players there are still a range of inhibiting taxes in place.

Foto: Colourbox

The repeal of the entrepreneurial tax, which was agreed by the Danish parliament shortly before Christmas, is positive news for the biotech industry, and it is expected to raise the incitation for investors, including business angels, to make investments of less than 10 % in Danish biotech companies.

Moreover, it will provide the companies with significantly easier access to risk capital, says the two corporate lawyers, Karin Absalonsen and Henrietta La Cour from Nyborg & Rørdam Advokatfirma in a column in the magazine MTI – Medicinsk Teknologi & Informatik (Medical Technology & Informatics).

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Her er de vigtigste nyheder fra MedWatch i uge 39

Et konsortium står til at overtage Ferrosan Medical Devices, der kan være klar til en børsnotering inden for en femårig tidshorisont. Derudover fortsætter kampen om medarbejderne i branchen, mens Novo Nordisk har indgået en ny aftale. Gik du glip af noget?

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier